Scinovex
articleTop 1% cited

Attributable Mortality of Nosocomial Candidemia, Revisited

Clinical Infectious Diseases · 2003 · Vol. 37(9) · pp. 1172–1177
Ólafur GuðlaugssonStephen H. GillespieKyungwon LeeJeffery Vande BergJun HuS. A. MesserLoreen A. HerwaldtMichael A. PfallerDaniel J. Diekema

Abstract

We reexamined the attributable mortality of nosocomial candidemia 15 years after a retrospective cohort study performed at our hospital demonstrated an attributable mortality of 38%. For all episodes of nosocomial candidemia between 1 July 1997 and 30 June 2001, we matched control patients with case patients by age, sex, date of hospital admission, underlying disease(s), length of time at risk, and surgical procedure(s). We analyzed 108 matched pairs. There were no statistically significant differences in age, sex, underlying disease(s), time at risk, surgical procedure, or vital signs at admission between cases and controls. The crude mortality among case patients was 61% (66 of 108 patients), compared with 12% (13 of 108) among control patients, for an attributable mortality of 49% (95% CI, 38%-60%). Nosocomial candidemia is still associated with an extremely high crude and attributable mortality--much higher than that expected from underlying disease alone.

Neutropenia and Cancer InfectionsBacterial Identification and Susceptibility TestingEnterobacteriaceae and Cronobacter ResearchMedicineRetrospective cohort studyDiseaseMortality ratePediatricsIntensive care medicineSurgeryInternal medicine

MeSH terms

Age FactorsAntifungal AgentsCandidaCandidiasisCross InfectionFemaleHumansLength of StayMaleMicrobial Sensitivity TestsMiddle AgedRetrospective StudiesSex FactorsCohort StudiesFluconazole
Citations
1,137
FWCI
19.42
field-weighted impact
References
37
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.